Skip to content

Protagonist Therapeutics

US · PTGX #1570 by market cap Listed 2016
121.40 -2.62 -2.11%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

About Protagonist Therapeutics

Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943. The company was founded by Mark L. Smythe on August 22, 2006 and is headquartered in Newark, CA.

Founded
2006
CEO
Dr. Dinesh V. Patel, PhD
Employees
132
Headquarters
Newark, California, United States of America
Fiscal year end
12-31
Website
protagonist-inc.com

Company profile

Exchange
US
Symbol
PTGX
Market-cap rank
#1570
Listing date
2016-08-11
Market cap
7.92B
Float cap
6.48B
Shares out
65.27M
Float shares
53.36M

Sectors & themes

Biotechnology Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Protagonist Therapeutics discussion 0 comments

Add a comment